Welcome to our dedicated page for HCM III Acquisition SEC filings (Ticker: HCMA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HCM III Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HCM III Acquisition's regulatory disclosures and financial reporting.
HCM III Acquisition Corp. (HCMA) filed its Q3 2025 report, detailing its post-IPO balance sheet and SPAC structure. The company completed its Initial Public Offering on August 4, 2025, selling 25,300,000 units at $10.00 each, including the full over-allotment. Simultaneously, it sold 4,266,667 private placement warrants for $6.4 million.
As of September 30, 2025, $254,727,160 was held in the Trust Account, primarily in U.S. Treasury-focused money market funds, while cash outside the trust was $1,144,833. Transaction costs totaled $17,106,910, including a deferred underwriting fee of $12,045,000 and an advisory fee payable of $1,204,500. The quarter showed net income of $390,364, driven by $1,727,160 of interest on trust investments and advisory fee reimbursements, offset by advisory expense and operating costs.
Class A ordinary shares subject to possible redemption were recorded at $254,727,160 (25,300,000 shares at $10.07 per share). As of November 14, 2025, shares issued and outstanding were 25,300,000 Class A and 8,433,333 Class B.
FAQ
What is the current stock price of HCM III Acquisition (HCMA)?
What is the market cap of HCM III Acquisition (HCMA)?
